Drug Approval | March 14, 2024
Zydus receives USFDA final approval for chlorpromazine hydrochloride injection
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
The product is expected to be launched in December 2023
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Multi-ethnic innovation helps all complexions appear clearer and more uniform
The product will be manufactured at Lupin’s Nagpur facility in India
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
This product will be manufactured at Lupin's Nagpur facility in India
Subscribe To Our Newsletter & Stay Updated
